Kennard K, Buckley ME, Sizer LM, Larson S, Carter WB, Frazier TG, Carp NZ. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population? Breast Cancer Res Treat. 2021 Jan 3. doi: 10.1007/s10549-020-06034-1.
Wadsworth B, Mann BD, Onyekere C, Ross S, Smith KF, Roberts S, Larson S. A Health System’s Interprofessional Approach to Impact Health Equity in Health Equity and Nursing: Achieving Equity Through Policy, Population Health, and Interprofessional Collaboration, ed. Moss MP, Phillips JM (Springer 2020).
Shahidullah JD, Kettlewell PW, DeHart KA, Larson SL, Bellino PJ. Interprofessional Training in Developmental and Behavioral Health Within a Pediatric Residency Program: An Organizational Systems Case Study, in Interprofessional Care Coordination for Pediatric Autism Spectrum Disorder, ed. Brunson McClain M, Shahidullah JD, Mezher KR. (Springer, 2020). pg. 437-58.
Patton DU, Frey WR, McGregor KA, et al. Contextual Analysis of Social Media: The Promise and Challenge of Eliciting Context in Social Medial Posts with Natural Language Processing. Proceedings of the 2020 AAAI/ACM Conference on AI, Ethics, and Society, Feb 7–8, 2020, New York.
Naureckas Li C, Sacks CA, McGregor KA, Masiakos PT, Flaherty MR. Screening for Access to Firearms by Pediatric Trainees in High-Risk Patients. Acad Pediatr. 2019;Mar 7, pii: S1876-2859(18)30544-8.
Ingram WM, Weston C, Dar Lu W, … Larson S. Factors Affecting Electroconvulsive Therapy Ictal Outcomes: Duration and Postictal Suppression. AMIA Jt Summits Transl Sci Proc. 2019 May 6:672-79.
Katsanis SH, Huang E, Young A, Grant V, Warner E, Larson S, Wagner JK. Caring for trafficked and unidentified patients in the EHR shadows: Shining a light by sharing the data. PLOS ONE 2019 14(3):e0213766.
McTigue KM, Hartelius EJ, … Larson SL, et al. Using a deliberative forum for engaging health system and health plan leaders to prioritize research topics. European Journal for Person Centered Healthcare. 2018; 6(2):228-36.
White papers and reports
Larson S; Padron N; Mason J; Bogaczyk T. Supervised Consumption Facilities – Review of the Evidence. December 2017.
CPHR produced a scientific review of safe injection sites as a means to help combat the opioid epidemic. The study was produced by CPHR at the request of The Office of the Health Commissioner, Philadelphia Department of Public Health. Supervised consumption facilities, also known as safe drug injection sites or comprehensive user engagement sites, are medical interventions in which essential services are provided to reduce substance use, the harms associated with substance abuse, and fatal overdoses.
In popular media
Robinson P, Onyekere C, Padron N. Know Your Community to Improve Population Health. Hospitals & Health Networks. March 2, 2017.
Chen AF, Padrón NA, Becker CM. The Social Determinants of Health. Healthcare Transformation. 2017;2(2):43-51.
Padron N. The Hard Truth Behind Philly Health Statistics. Philadelphia magazine. May 6, 2017.
Larson S. With suicide on the rise, it should now be viewed as a population health problem. Main Line Health Well Ahead blog. July 10, 2018.
Kaitlyn Kennard, Meghan Buckley, Sharon Larson, et al. Metabolic Syndrome: Does This Influence Breast Cancer Outcomes in the Triple Negative Population? Poster presented to the Society of Surgical Oncology, virtual conference held Aug. 2020.
Kaitlyn Kennard, Megan Buckley, Sam Meske, Sharon Larson, et al. Use of PECS II Block in Partial Mastectomy for Improving Postoperative Pain Control and Mitigating Narcotic Use: Initial Results from a Randomized Control Trial. Poster presented to the ASBrS virtual conference, June 2020.
Chodick G, Leader AE, Larson S. Uptake of Papanicolaou testing by HPV vaccination status (PDF). Poster presented at the International Society for Pharmacoepidemiology, 2019; Philadelphia.
Williams A, Buckley M, Ciocca R, Sabol J, Larson S, Carp N. Racial and Economic Disparities in Breast Cancer Incidence and Mortality in Pennsylvania (PDF). Poster presented at the Society of Surgical Oncology Annual Cancer Symposium, 2019; San Diego.
Larson S, Padron N, Bogaczyk T, Mason J. Supervised consumption facilities — a review of the evidence (PDF). Poster presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2018 conference. May 2018; Baltimore, MD.
Larson S, Padron N. The case for harm reduction in Philadelphia. Poster presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2018 conference. May 2018; Baltimore, MD.
Larson S. Factors associated with secondary non-adherence to oral hypoglycemic among patients with type 2 diabetes (PDF). American Diabetes Association Scientific Sessions. June 2018; Orlando, FL.